Skip to content

Chartis Console

by Pulmonx, Inc. 2 variants

510(k) K111764

Chartis Console is a medical device (FDA Class II; FDA product code BZG, Spirometer, Diagnostic) made by Pulmonx, Inc., cleared under FDA 510(k) K111764 on 10 Nov 2011, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK111764 Date10 Nov 2011ClearedStatusActive

Official records

From the FDA record

Received by the FDA
23 Jun 2011
FDA decision
10 Nov 2011 (Substantially Equivalent)
FDA review time
140 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K111764 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
BZG
Device class
Class II
Regulation
21 CFR Part 868.1840
Advisory committee
Anesthesiology
FDA decision
SESE Substantially Equivalent

Devices cleared under K111764

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K111764
UDI-DISize and differences
Chartis Console G3
Pulmonx Corporation
CHR-CO-100 / G3M776CHRCO100 —On the market

Similar devices

Other devices filed under FDA product code BZG (Spirometer, Diagnostic).

Other devices from Pulmonx Corporation

See all devices from Pulmonx Corporation →